media monitoring AI limitations
Our Blog
Featured Post
Latest Posts
Google’s AI Medical Chatbot Draws Skepticism From Medical Professionals Artificial Intelligence urges the pharma industry to reorganize business models and rationalize biopharma manufacturing as it enhances financial...
Question: If research is performed alone and in a vacuum, does anyone care? Answer: Probably not (other than the researcher). That’s why the 26th annual International Public...
Dashboards aren’t new, but what we can do with them in the near future will be. In early February, Fullintel released its first phase of its dashboards...
Fullintel’s Angela Dwyer is now an advisory board member for Fierce Pharma’s PR and Communications Summit! Angela joins a star-studded roster of pharma and communications leaders tasked...
Keeping up to date on trends from social media, tech, the news industry and even social media memes is nigh impossible unless you have boundless time. This...
Research and development. R&D. Skunk works. Whatever you call it, when I think about great products and the teams that build them I’m reminded of Batman’s fictional...
The Ethical and Legal Concerns of ChatGPT Strike the Pharma Industry The pharmaceutical industry is one of the most powerful, volatile and resourceful sectors of the global...
When I think about crises, I often think about the metaphor of the “straw that broke the camel’s back”. The straw can come from anywhere in your...
Industry conferences are nearly every PR professional’s dream. Get in front of your piers, present your work, or get out your notepad and listen to amazing research....
Elon Musk’s Neuralink Brain Chip Tech Sparks A Wave of Innovation – Experts Remain Skeptical About the Company’s Prospects The modern pharmaceutical industry is a highly globalized...
Members of the IPR Measurement Commission gathered virtually to discuss earned media measurement. IPR Measurement Commission member Angela Dwyer, Head of Insights at Fullintel, moderated the discussion.
...